Adjuvant therapy for high-risk medulloblastoma: more is better?
作者信息
Strother Douglas, Lafay-Cousin Lucie
机构信息
Section of Pediatric Hematology Oncology and Bone Marrow Transplantation, Alberta Children's Hospital and Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
出版信息
Neuro Oncol. 2021 Jul 1;23(7):1048-1049. doi: 10.1093/neuonc/noab104.
Abstract
摘要
相似文献
1
Adjuvant therapy for high-risk medulloblastoma: more is better?高危髓母细胞瘤的辅助治疗：越多越好？
Neuro Oncol. 2021 Jul 1;23(7):1048-1049. doi: 10.1093/neuonc/noab104.
2
[Medulloblastoma in adults: report of 13 cases and literature review].[成人髓母细胞瘤：13例报告及文献复习]
Pan Afr Med J. 2015 Oct 12;22:126. doi: 10.11604/pamj.2015.22.126.7242. eCollection 2015.
3
Risk-adapted chemotherapy in childhood medulloblastoma.儿童髓母细胞瘤的风险适应性化疗。
Expert Rev Anticancer Ther. 2011 May;11(5):771-80. doi: 10.1586/era.10.222.
4
Medulloblastoma.髓母细胞瘤
Eur J Cancer. 2011 Sep;47 Suppl 3:S338. doi: 10.1016/S0959-8049(11)70194-0.
5
Medulloblastoma.髓母细胞瘤
Arch Dis Child. 1992 May;67(5):572-3. doi: 10.1136/adc.67.5.572.
6
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.成人髓母细胞瘤：诊断及复发时的预后因素与治疗反应
J Neurol. 2005 Mar;252(3):291-9. doi: 10.1007/s00415-005-0560-2. Epub 2005 Feb 23.
7
[Therapy of medulloblastomas--results from 1968 to 1985].[髓母细胞瘤的治疗——1968年至1985年的结果]
Strahlenther Onkol. 1990 Oct;166(10):683-7.
8
Recurrent medulloblastoma in children.儿童复发性髓母细胞瘤
Neurol Med Chir (Tokyo). 1986 Jan;26(1):19-25. doi: 10.2176/nmc.26.19.
9
Past, current and future protocols for combined modality therapy in childhood medulloblastoma.儿童髓母细胞瘤联合治疗的过去、当前及未来方案
Expert Rev Anticancer Ther. 2003 Feb;3(1):79-90. doi: 10.1586/14737140.3.1.79.
10
Current multimodality management of medulloblastoma.髓母细胞瘤的当前多模态管理
Curr Probl Cancer. 2002 Nov-Dec;26(6):317-56. doi: 10.1067/mcn.2002.130267.
引用本文的文献
1
Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients.成人高危髓母细胞瘤和松果体母细胞瘤患者的强化儿科化疗方案（PNET HR+5）
Neurooncol Adv. 2024 Aug 10;6(1):vdae141. doi: 10.1093/noajnl/vdae141. eCollection 2024 Jan-Dec.
2
Role of Circular RNA in Brain Tumor Development.环状 RNA 在脑肿瘤发展中的作用。
Cells. 2022 Jul 6;11(14):2130. doi: 10.3390/cells11142130.
3
Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.影响小儿髓母细胞瘤治疗的亚组特异性诊断、预后和预测标志物
Diagnostics (Basel). 2021 Dec 28;12(1):61. doi: 10.3390/diagnostics12010061.
本文引用的文献
1
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).调整风险适应治疗的儿童髓母细胞瘤的临床和分子特征的结果：一项国际 III 期试验（SJMB03）的结果。
J Clin Oncol. 2021 Mar 1;39(7):822-835. doi: 10.1200/JCO.20.01372. Epub 2021 Jan 6.
2
Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5.高危型髓母细胞瘤患儿在 II 期试验 PNET HR+5 中的临床和分子危险因素的预后相关性。
Neuro Oncol. 2021 Jul 1;23(7):1163-1172. doi: 10.1093/neuonc/noaa301.
3
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.儿童和青少年转移性髓母细胞瘤的治疗及临床和生物学参数的预后相关性。
J Clin Oncol. 2016 Dec;34(34):4151-4160. doi: 10.1200/JCO.2016.67.2428. Epub 2016 Oct 31.
4
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.颅脊柱放疗期间用卡铂治疗转移性髓母细胞瘤患儿的结果：一项儿童肿瘤学组 I/II 期研究。
J Clin Oncol. 2012 Jul 20;30(21):2648-53. doi: 10.1200/JCO.2011.40.2792. Epub 2012 Jun 4.
5
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.米兰转移性髓母细胞瘤治疗策略中的超分割加速放疗
J Clin Oncol. 2009 Feb 1;27(4):566-71. doi: 10.1200/JCO.2008.18.4176. Epub 2008 Dec 15.
6
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.风险适应性颅脊髓放疗联合大剂量化疗及干细胞救援用于新诊断髓母细胞瘤患儿（圣裘德儿童研究医院髓母细胞瘤-96研究）：一项前瞻性多中心试验的长期结果
Lancet Oncol. 2006 Oct;7(10):813-20. doi: 10.1016/S1470-2045(06)70867-1.
7
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.新诊断的平均风险髓母细胞瘤采用颅脊髓放射治疗后辅助化疗的III期研究。
J Clin Oncol. 2006 Sep 1;24(25):4202-8. doi: 10.1200/JCO.2006.06.4980.
Zotero 插件